Abstract
Regenerating gene IV (RegIV), a member of the regenerating gene family discovered in 2001, has been found to be involved in malignancy in several different organs including the stomach, colorectum, pancreas and prostate, but the overall expression profile of RegIV has not been reported. To learn more about RegIV, we evaluated its distribution by immunohistochemistry (IHC) in a total of 360 samples including 24 types of normal tissue, 40 benign and malignant lesions, and 18 neuroendocrine tumors. We found that in normal tissues, in addition to its relative specificity for the gastrointestinal tract, RegIV was detected in the adrenal gland and mammary gland. Among all the malignancies of various histological types under evaluation, RegIV was found mostly in adenocarcinomas. Studies on additional sets of colorectal tumor samples showed that RegIV expression was predominant in colorectal adenoma (87.5%) and peritumoral tissue (100%) but not in cancer tissue (30.8%). Among neuroendocrine tumors, RegIV had a relatively restricted expression to those of digestive system.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bishnupuri, K.S., Luo, Q., Korzenik, J.R., Henderson, J.O., Houchen, C.W., Anant, S., Dieckgraefe, B.K., 2006a. Dysregulation of Reg gene expression occurs early in gastrointestinal tumorigenesis and regulates anti-apoptotic genes. Cancer Biol. Ther., 5(12):1714–1720.
Bishnupuri, K.S., Luo, Q., Murmu, N., Houchen, C.W., Anant, S., Dieckgraefe, B.K., 2006b. RegIV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas. Gastroenterology, 130(1): 137–149. [doi:10.1053/j.gastro.2005.10.001]
Campbell, L.K., Thomas, J.R., Lamps, L.W., Smoller, B.R., Folpe, A.L., 2003. Protein gene product 9.5 (PGP 9.5) is not a specific marker of neural and nerve sheath tumors: an immunohistochemical study of 95 mesenchymal neoplasms. Mod. Pathol., 16(10):963–969. [doi:10.1097/01.MP.0000087088.88280.B0]
Chen, L.C., Hao, C.Y., Chiu, Y.S., Wong, P., Melnick, J.S., Brotman, M., Moretto, J., Mendes, F., Smith, A.P., Bennington, J.L., et al., 2004. Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients. Cancer Res., 64(10): 3694–3700. [doi:10.1158/0008-5472.CAN-03-3264]
Dhar, D.K., Udagawa, J., Ishihara, S., Otani, H., Kinoshita, Y., Takasawa, S., Okamoto, H., Kubota, H., Fujii, T., Tachibana, M., et al., 2004. Expression of regenerating gene I in gastric adenocarcinomas: correlation with tumor differentiation status and patient survival. Cancer, 100(6): 1130–1136. [doi:10.1002/cncr.20097]
Gu, Z., Rubin, M.A., Yang, Y., Deprimo, S.E., Zhao, H., Horvath, S., Brooks, J.D., Loda, M., Reiter, R.E., 2005. RegIV: a promising marker of hormone refractory metastatic prostate cancer. Clin. Cancer Res., 11(6): 2237–2243. [doi:10.1158/1078-0432.CCR-04-0356]
Gurr, W., Yavari, R., Wen, L., Shaw, M., Mora, C., Christa, L., Sherwin, R.S., 2002. A Reg family protein is overexpressed in islets from a patient with new-onset type 1 diabetes and acts as T-cell autoantigen in NOD mice. Diabetes, 51(2):339–346. [doi:10.2337/diabetes.51.2.339]
Hartupee, J.C., Zhang, H., Bonaldo, M.F., Soares, M.B., Dieckgraefe, B.K., 2001. Isolation and characterization of a cDNA encoding a novel member of the human regenerating protein family: RegIV. Biochim. Biophys. Acta, 1518(3):287–293.
Kamarainen, M., Heiskala, K., Knuutila, S., Heiskala, M., Winqvist, O., Andersson, L.C., 2003. RELP, a novel human REG-like protein with up-regulated expression in inflammatory and metaplastic gastrointestinal mucosa. Am. J. Pathol., 163(1):11–20.
Kimura, N., Pilichowska, M., Okamoto, H., Kimura, I., Aunis, D., 2000. Immunohistochemical expression of chromogranins A and B, prohormone convertases 2 and 3, and amidating enzyme in carcinoid tumors and pancreatic endocrine tumors. Mod. Pathol., 13(2):140–146. [doi:10. 1038/modpathol.3880026]
Mani, S., Modlin, I.M., Ballantyne, G., Ahlman, H., West, B., 1994. Carcinoids of the rectum. J. Am. Coll. Surg., 179(2): 231–248.
Nanakin, A., Fukui, H., Fujii, S., Sekikawa, A., Kanda, N., Hisatsune, H., Seno, H., Konda, Y., Fujimori, T., Chiba, T., 2007. Expression of the RegIV gene in ulcerative colitis. Lab. Invest., 87(3):304–314. [doi:10.1038/labinvest. 3700507]
Oue, N., Mitani, Y., Aung, P.P., Sakakura, C., Takeshima, Y., Kaneko, M., Noguchi, T., Nakayama, H., Yasui, W., 2005. Expression and localization of RegIV in human neoplastic and non-neoplastic tissues: RegIV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. J. Pathol., 207(2):185–198. [doi:10.1002/path.1827]
Oue, N., Kuniyasu, H., Noguchi, T., Sentani, K., Ito, M., Tanaka, S., Setoyama, T., Sakakura, C., Natsugoe, S., Yasui, W., 2007. Serum concentration of RegIV in patients with colorectal cancer: overexpression and high serum levels of RegIV are associated with liver metastasis. Oncology, 72(5-6):371–380. [doi:10.1159/000113147]
Sekikawa, A., Fukui, H., Fujii, S., Nanakin, A., Kanda, N., Uenoyama, Y., Sawabu, T., Hisatsune, H., Kusaka, T., Ueno, S., et al., 2005. Possible role of Reg Iα protein in ulcerative colitis and colitic cancer. Gut, 54(10):1437–1444. [doi:10.1136/gut.2004.053587]
Takehara, A., Eguchi, H., Ohigashi, H., Ishikawa, O., Kasugai, T., Hosokawa, M., Katagiri, T., Nakamura, Y., Nakagawa, H., 2006. Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4. Cancer Sci., 97(11): 1191–1197. [doi:10.1111/j.1349-7006.2006.00297.x]
Violette, S., Festor, E., Pandrea-Vasile, I., Mitchell, V., Adida, C., Dussaulx, E., Lacorte, J.M., Chambaz, J., Lacasa, M., Lesuffleur, T., 2003. RegIV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas. Int. J. Cancer, 103(2):185–193. [doi:10.1002/ ijc.10788]
Yao, J.C., Hassan, M., Phan, A., Dagohoy, C., Leary, C., Mares, J.E., Abdalla, E.K., Fleming, J.B., Vauthey, J.N., Rashid, A., et al., 2008. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35 825 cases in the United States. J. Clin. Oncol., 26(18):3063–3072. [doi:10.1200/JCO.2007. 15.4377]
Zhang, Y.W., Lai, M.D., Lv, B.J., Gu, X.M., Wang, H., Zhu, Y.M., Shao, L.N., Wang, G.F., 2003a. Overexpression of RegIV in colorectal adenoma. Cancer Lett., 200(1):69–76. [doi:10.1016/S0304-3835(03)00460-9]
Zhang, Y.W., Ding, L.S., Lai, M.D., 2003b. Reg gene family and human diseases. World J. Gastroenterol., 9(12): 2635–2641.
Zheng, H.C., Xu, X.Y., Yu, M., Takahashi, H., Masuda, S., Takano, Y., 2010. The role of RegIV gene and its encoding product in gastric carcinogenesis. Hum. Pathol., 41(1):59–69. [doi:10.1016/j.humpath.2009.06.013]
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the International Cooperation Program (No. 2007C24009), the Major Project of Natural Foundation of Zhejiang Province (No. D2080011), the Major Special Project of Science and Technology Found of Zhejiang Province (No. 2007C3020) and the Natural Science Foundation of Zhejiang Province, China (No. Y2090152)
An erratum to this article can be found at http://dx.doi.org/10.1631/jzus.B09e0383
Rights and permissions
About this article
Cite this article
Li, Fy., Ren, Xb., Xu, Ep. et al. RegIV expression showing specificity to gastrointestinal tract and its potential role in diagnosing digestive tract neuroendocrine tumor. J. Zhejiang Univ. Sci. B 11, 258–266 (2010). https://doi.org/10.1631/jzus.B0900383
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1631/jzus.B0900383